NasdaqGS - Delayed Quote • USD Medpace Holdings, Inc. (MEDP) Follow Add holdings 298.25 -5.75 (-1.89%) At close: June 13 at 4:00:01 PM EDT 297.00 -1.25 (-0.42%) After hours: June 13 at 4:39:53 PM EDT All News Press Releases SEC Filings Medpace Holdings, Inc. (MEDP): A Bull Case Theory We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on Substack by Compound & Fire. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc. (MEDP)’s share was trading at $305.98 as of May 19th. MEDP’s trailing and forward P/E were 23.36 and 24.88 respectively according to Yahoo Finance. Medpace Holdings […] MEDP Q1 Earnings Call: Outperformance Driven by Revenue Upside, Cautious Outlook Amid Funding Uncertainty Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance of $2.19 billion at the midpoint came in 2% above analysts’ estimates. Its GAAP profit of $3.67 per share was 20.8% above analysts’ consensus estimates. When Should You Buy Medpace Holdings, Inc. (NASDAQ:MEDP)? Medpace Holdings, Inc. ( NASDAQ:MEDP ), is not the largest company out there, but it saw significant share price... Healthcare stocks: No longer a safe space for investors? Healthcare used to be considered a safe, constant growth sector, weighted heavily in some 401(k)s. But it isn't immune to current market volatility. Healthcare sector under pressure as market weighs Trump impact The S&P Biotech sector (XBI) has outperformed the S&P 500 (^GSPC) since 2021. Yahoo Finance Senior Health Reporter Anjalee Khemlani sits down with Catalysts host Madison Mills to take a closer look at the healthcare sector (XLV), specifically Medpace Holdings (MEDP) and Intuitive Surgical (ISRG), as uncertainty grows on the impact of President Trump's policy changes. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. MEDP Q1 Earnings Call: Revenue Beats Expectations Amid Cancellations and Industry Headwinds Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance of $2.19 billion at the midpoint came in 2% above analysts’ estimates. Its GAAP profit of $3.67 per share was 20.8% above analysts’ consensus estimates. Medpace Holdings First Quarter 2025 Earnings: Beats Expectations Medpace Holdings ( NASDAQ:MEDP ) First Quarter 2025 Results Key Financial Results Revenue: US$558.6m (up 9.3% from 1Q... Medpace Holdings Inc (MEDP) Q1 2025 Earnings Call Highlights: Revenue Growth Amidst Competitive ... Medpace Holdings Inc (MEDP) reports a 9.3% revenue increase in Q1 2025, while navigating decreased new business awards and intensified market competition. Medpace Hits 17-Month Low After Bookings Miss Leaves Investors Mystified Medpace stock tumbled Tuesday after lighter-than-expected bookings in the March quarter "cast more doubt on the path forward." Why Medpace (MEDP) Stock Is Trading Lower Today Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 11.2% in the pre-market session after the company reported first-quarter 2025 earnings with high expectations heading into the quarter, dampening the otherwise decent results. A key concern was the 19% decline in net new bookings. Also, the drop in the book-to-bill ratio to 0.90x further suggested future bookings were slowing, which might explain why investors didn't cheer louder. Medpace (NASDAQ:MEDP) Beats Expectations in Strong Q1 But Stock Drops Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance of $2.19 billion at the midpoint came in 1.9% above analysts’ estimates. Its GAAP profit of $3.67 per share was 20.8% above analysts’ consensus estimates. Medpace: Q1 Earnings Snapshot CINCINNATI (AP) — Medpace Holdings Inc. MEDP) on Monday reported first-quarter net income of $114.6 million. On a per-share basis, the Cincinnati-based company said it had net income of $3.67. Medpace Holdings, Inc. Reports First Quarter 2025 Results CINCINNATI, April 21, 2025--Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the first quarter ended March 31, 2025. Medpace (MEDP) Q1 Earnings: What To Expect Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market close. Here’s what you need to know. What Makes Medpace Holdings (MEDP) a Better Investment? Giverny Capital Asset Management, LLC, an investment management company, recently published its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio returned -3.39% in the quarter, compared to a -4.27% return for the S&P 500 Total Return Index. For the year ended March 31, 2025, the fund returned 1.75% […] What Makes Medpace Holdings (MEDP) an Investment Bet? Investment management company Vulcan Value Partners recently released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The first quarter experienced the return of volatility. The companies’ management teams expressed a more cautious view following the recent election. Optimism has given way to uncertainty about tariffs and potential impacts on earnings, inflation, and […] Are Investors Undervaluing Medpace Holdings, Inc. (NASDAQ:MEDP) By 48%? Key Insights Using the 2 Stage Free Cash Flow to Equity, Medpace Holdings fair value estimate is US$584 Medpace... Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Is Well Worth Watching Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks... Here’s How LVS Advisory Embraced Change in Medpace Holdings (MEDP) Investments LVS Advisory, a New York City-based full-service investment firm, recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. The LVS Event-Driven portfolio had a strong performance in 2024 with a 7.5% (net of fees) return, despite a challenging environment for the asset class. The LVS Growth Portfolio delivered […] Is Medpace Holdings, Inc. (MEDP) the Best Diagnostics Stock to Invest in Right Now? We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Medpace Holdings, Inc. (NASDAQ:MEDP) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics Market According to a report by […] Performance Overview Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return MEDP S&P 500 (^GSPC) YTD -10.23% +1.62% 1-Year -24.32% +10.00% 3-Year +120.19% +59.40%